CIBC Bancorp USA Inc. Buys Shares of 23,194 HCA Healthcare, Inc. $HCA

CIBC Bancorp USA Inc. bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 23,194 shares of the company’s stock, valued at approximately $9,885,000.

Several other institutional investors have also added to or reduced their stakes in HCA. Cerity Partners LLC increased its position in shares of HCA Healthcare by 13.1% in the third quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock worth $18,719,000 after purchasing an additional 5,092 shares during the last quarter. Swiss National Bank grew its stake in HCA Healthcare by 4.3% in the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after buying an additional 23,100 shares in the last quarter. National Pension Service raised its position in shares of HCA Healthcare by 2.9% during the 3rd quarter. National Pension Service now owns 626,585 shares of the company’s stock valued at $267,051,000 after buying an additional 17,531 shares in the last quarter. Savant Capital LLC grew its position in HCA Healthcare by 37.7% in the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after acquiring an additional 1,246 shares in the last quarter. Finally, Sector Gamma AS raised its position in HCA Healthcare by 36.0% during the third quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock valued at $4,638,000 after purchasing an additional 2,883 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Jim Cramer publicly recommended buying HCA, calling it a buy in “big clumps,” which can drive retail interest and short‑term inflows. Jim Cramer on HCA Healthcare
• Positive Sentiment: HCA hospitals received regional/national recognition (Ocala hospitals praised for patient safety; HCA Florida North Florida Hospital named to America’s 250 Best Hospitals), which supports brand, referrals and patient volumes. Ocala hospitals honored for excellence in patient safety
• Positive Sentiment: HCA Florida North Florida Hospital included among America’s 250 Best Hospitals, reinforcing quality credentials that can protect pricing and payer relationships. HCA Florida North Florida Hospital among America’s 250 Best Hospitals
• Positive Sentiment: Virginia regulators approved new hospitals/expansions that include HCA projects, supporting medium‑term revenue growth and market share in that region. State approves three Chesterfield hospital projects
• Neutral Sentiment: Human-interest coverage (a North Carolina NICU St. Patrick’s Day feature) highlights community care but is unlikely to move the stock materially. North Carolina NICU Celebrates St. Patrick’s Day
• Negative Sentiment: HCA’s board urged shareholders to reject a proposal for fuller reporting on the aftermath of the 2019 Mission sale — a governance/oversight flashpoint that can raise investor concern and activist interest. HCA board urges shareholders to reject proposal
• Negative Sentiment: An HCA hospital CEO is leaving for Beth Israel Lahey Health — an executive departure that may be seen as local leadership turnover and could modestly concern investors about continuity in affected markets. HCA hospital CEO heads to Beth Israel Lahey Health

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 8,020 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the transaction, the senior vice president owned 11,993 shares in the company, valued at $6,171,357.94. This trade represents a 40.07% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the transaction, the executive vice president owned 8,853 shares of the company’s stock, valued at $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 15,214 shares of company stock worth $7,797,595 in the last quarter. 1.30% of the stock is owned by company insiders.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $493.61 on Friday. The firm has a market capitalization of $110.36 billion, a PE ratio of 17.39, a PEG ratio of 1.53 and a beta of 1.34. The stock has a fifty day simple moving average of $510.01 and a two-hundred day simple moving average of $473.08. HCA Healthcare, Inc. has a 52-week low of $314.43 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter last year, the business posted $6.22 earnings per share. The firm’s revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is 10.99%.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent research reports. Royal Bank Of Canada increased their price objective on HCA Healthcare from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Barclays boosted their price objective on shares of HCA Healthcare from $494.00 to $551.00 and gave the stock an “overweight” rating in a report on Wednesday, January 28th. Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 29th. KeyCorp set a $503.00 price objective on HCA Healthcare in a report on Wednesday, January 28th. Finally, Oppenheimer increased their target price on HCA Healthcare from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $537.73.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.